+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Report
  • May 2023
  • 391 Pages
  • Global
From
Cancer Monoclonal Antibodies Market Report by Antibody Type, Medication Type, Application, End-User, and Region 2024-2032 - Product Thumbnail Image

Cancer Monoclonal Antibodies Market Report by Antibody Type, Medication Type, Application, End-User, and Region 2024-2032

  • Report
  • April 2024
  • 136 Pages
  • Global
From
US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
Acute Lymphoblastic Leukemia Treatment Market by Types of Cell, Therapy, End-User - Global Forecast 2025-2030 - Product Thumbnail Image

Acute Lymphoblastic Leukemia Treatment Market by Types of Cell, Therapy, End-User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 198 Pages
  • Global
From
Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates) - Product Thumbnail Image

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

  • Report
  • February 2022
  • 84 Pages
  • Global
From
Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029 - Product Thumbnail Image

Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029

  • Report
  • March 2024
  • 1200 Pages
  • Global
From
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 407 Pages
  • Global
From
CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027 - Product Thumbnail Image

CD137 Antibodies Clinical Trials & Market Opportunity Insight 2027

  • Report
  • September 2024
  • 210 Pages
  • Global
From
Global Trispecific Antibodies Clinical Trials & Market Outlook 2024 - Product Thumbnail Image

Global Trispecific Antibodies Clinical Trials & Market Outlook 2024

  • Report
  • June 2024
  • 140 Pages
  • Global
From
Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

  • Report
  • October 2023
  • 470 Pages
  • Global
From
Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 - Product Thumbnail Image

Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030

  • Report
  • October 2024
  • 1300 Pages
  • Global
From
Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • October 2022
  • 338 Pages
  • Asia Pacific, Global, ... Asia Pacific, Global, Europe
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 214 Pages
  • Global
From
Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028 - Product Thumbnail Image

Anti-CD20 Monoclonal Antibodies (mABs) Market 2024-2028

  • Report
  • October 2023
  • 161 Pages
  • Global
From
Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033 - Product Thumbnail Image

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

  • Report
  • December 2023
  • 134 Pages
  • Global
From
Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028

  • Report
  • August 2022
  • 600 Pages
  • Global
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028

  • Report
  • July 2022
  • 2190 Pages
  • Global
From
Loading Indicator